Lori Buetow

Lori Buetow

Auto-generated profile, based on publicly available information

Lori Buetow

Cancer Research UK Scotland Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
CCChatrin Chatrin
Chatrin Chatrin
MGMads Gabrielsen
Mads Gabrielsen
LBLori Buetow
Lori Buetow
MNMark A. Nakasone
Mark A. Nakasone
SASyed F. Ahmed
Syed F. Ahmed
DHDanny T. Huang
Danny T. Huang
Cellular cross-talk between ubiquitination and other posttranslational modifications contributes to the regulation of numerous processes. One example is ADP-ribosylation of the carboxyl terminus of ubiquitin by the E3 DTX3L/ADP-ribosyltransferase PARP9 heterodimer, but the mechanism remains elusive. Here, we show that independently of PARP9, the conserved carboxyl-terminal RING and DTC (Deltex carboxyl-terminal) domains of DTX3L and other human Deltex proteins (DTX1 to DTX4) catalyze ADP-ribosylation of ubiquitin’s Gly76. Structural studies reveal a hitherto unknown function of the DTC domain in binding NAD+. Deltex RING domain recruits E2 thioesterified with ubiquitin and juxtaposes it with NAD+ bound to the DTC domain to facilitate ADP-ribosylation of ubiquitin. This ubiquitin modification prevents its activation but is reversed by the linkage nonspecific deubiquitinases. Our study provides mechanistic insights into ADP-ribosylation of ubiquitin by Deltex E3s and will enable future studies directed at understanding the increasingly complex network of ubiquitin cross-talk.

21 August 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
SASyed Feroj Ahmed
Syed Feroj Ahmed
LBLori Buetow
Lori Buetow
MGMads Gabrielsen
Mads Gabrielsen
SLSergio Lilla
Sergio Lilla
CCChatrin Chatrin
Chatrin Chatrin
DHDanny T. Huang
Danny T. Huang
The C-terminal domain of DELTEX E3s binds ADP-ribose and promotes ubiquitination of poly-ADP-ribosylated substrates.

20 October 2007 in Acta Crystallographica Section F Structural Biology and Crystallization Communications
Verified
Journal Article
Open access
PDF file
VUVenkatasubramanian Ulaganathan
Venkatasubramanian Ulaganathan
MAMark F. Agacan
Mark F. Agacan
LBLori Buetow
Lori Buetow
LTLindsay B. Tulloch
Lindsay B. Tulloch
WHWilliam N. Hunter
William N. Hunter
Vitamin K(2), or menaquinone, is an essential cofactor for many organisms and the enzymes involved in its biosynthesis are potential antimicrobial drug targets. One of these enzymes, 1,4-dihydroxy-2-naphthoyl-CoA synthase (MenB) from the pathogen Staphylococcus aureus, has been obtained in recombinant form and its quaternary structure has been analyzed in solution. Cubic crystals of the enzyme allowed a low-resolution structure (2.9 A) to be determined. The asymmetric unit consists of two subunits and a crystallographic threefold axis of symmetry generates a hexamer consistent with size-exclusion chromatography. Analytical ultracentrifugation indicates the presence of six states in solution, monomeric through to hexameric, with the dimer noted as being particularly stable. MenB displays the crotonase-family fold with distinct N- and C-terminal domains and a flexible segment of structure around the active site. The smaller C-terminal domain plays an important role in oligomerization and also in substrate binding. The presence of acetoacetyl-CoA in one of the two active sites present in the asymmetric unit indicates how part of the substrate binds and facilitates comparisons with the structure of Mycobacterium tuberculosis MenB.

14 August 2023 in The EMBO Journal
Verified
Journal Article
Open access
KNKonstantina Nikolatou
Konstantina Nikolatou
ESEmma Sandilands
Emma Sandilands
ARAlvaro Román‐Fernández
Alvaro Román‐Fernández
ECErin M Cumming
Erin M Cumming
EFEva Freckmann
Eva Freckmann
DBDavid M Bryant
David M Bryant
Dysregulation of the PI3K/AKT pathway is a common occurrence in high‐grade serous ovarian carcinoma (HGSOC), with the loss of the tumour suppressor PTEN in HGSOC being associated with poor prognosis. The cellular mechanisms of how PTEN loss contributes to HGSOC are largely unknown. We here utilise time‐lapse imaging of HGSOC spheroids coupled to a machine learning approach to classify the phenotype of PTEN loss. PTEN deficiency induces PI(3,4,5)P 3 ‐rich and ‐dependent membrane protrusions into the extracellular matrix (ECM), resulting in a collective invasion phenotype. We identify the small GTPase ARF6 as a crucial vulnerability of HGSOC cells upon PTEN loss. Through a functional proteomic CRISPR screen of ARF6 interactors, we identify the ARF GTPase‐activating protein (GAP) AGAP1 and the ECM receptor β1‐integrin (ITGB1) as key ARF6 interactors in HGSOC regulating PTEN loss‐associated invasion. ARF6 functions to promote invasion by controlling the recycling of internalised, active β1‐integrin to maintain invasive activity into the ECM. The expression of the CYTH2‐ARF6‐AGAP1 complex in HGSOC patients is inversely associated with outcome, allowing the identification of patient groups with improved versus poor outcome. ARF6 may represent a therapeutic vulnerability in PTEN‐depleted HGSOC.

15 January 2025 in RSC Chemical Biology
Verified
Journal Article
Open access
PDF file
DMDanielle C. Morgan
Danielle C. Morgan
LMLaura McDougall
Laura McDougall
AKAstrid Knuhtsen
Astrid Knuhtsen
LBLori Buetow
Lori Buetow
CSCraig F. Steven
Craig F. Steven
AJAndrew Jamieson
Andrew Jamieson
Peptide stapling is an effective strategy to stabilise α-helical peptides, enhancing their bioactive conformation and improving physiochemical properties. In this study, we apply our novel diyne-girder stapling approach to the MDM2/MDMX α-helical binding region of the p53 transactivation domain. By incorporation of an unnatural amino acid to create an optimal i, i + 7 bridge length, we developed a highly α-helical stapled peptide, 4, confirmed via circular dichroism. This diyne-girder-stapled peptide demonstrated enhanced helicity and nanomolar binding affinity for MDM2, as assessed by fluorescence polarisation. Crucially, peptide 4 exhibited strong selectivity for MDM2, with approximately 100-fold reduced affinity for MDMX. Molecular modeling and docking studies suggested that this selectivity arose from diminished hydrophobic interactions at the MDMX binding site, driven by the diyne-girder's constrained geometry. The use of the diyne-girder, a unique feature amongst stapled peptide analogues, for cellular visualisation using Raman spectroscopy in the “cell-silent” region was explored. This capability potentially offers a novel method for tracking stapled peptides in biological systems without the need for large fluorophores. Overall, peptide 4 represents a promising tool for probing MDM2 activity and a valuable addition to the arsenal of peptide-based therapeutic strategies.